Warning: The NCBI web site requires JavaScript to function. more...
A monoclonal antibody against kininogen reduces inflammation in the HLA-B27 transgenic rat.
Keith JC Jr, Sainz IM, Isordia-Salas I, Pixley RA, Leathurby Y, Albert LM, Colman RW.
Arthritis Res Ther. 2005;7(4):R769-76. Epub 2005 Apr 4.
Related citations
A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis.
Espinola RG, Uknis A, Sainz IM, Isordia-Salas I, Pixley R, DeLa Cadena R, Long W, Agelan A, Gaughan J, Adam A, Colman RW.
Am J Pathol. 2004 Sep;165(3):969-76.
Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease.
Peterson RL, Wang L, Albert L, Keith JC Jr, Dorner AJ.
Lab Invest. 1998 Dec;78(12):1503-12.
CD8 alpha beta T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats.
May E, Dorris ML, Satumtira N, Iqbal I, Rehman MI, Lightfoot E, Taurog JD.
J Immunol. 2003 Jan 15;170(2):1099-105.
Inhibitory effects of the new anti-inflammatory agent, IS-741, on spontaneous colitis in HLA-B27/beta2-microglobulin transgenic rats.
Makino J, Andoh A, Hata K, Yotsuya S, Shikama H, Imamura M, Fujiyama Y, Bamba T.
J Gastroenterol Hepatol. 2002 Aug;17(8):854-60.
Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: modulation by a selective plasma kallikrein inhibitor.
Colman RW, Stadnicki A, Kettner CA, Adam AA, DeLa Cadena RA, Sartor RB.
Proc Assoc Am Physicians. 1997 Jan;109(1):10-22.
Inflammatory disease in HLA-B27 transgenic rats.
Taurog JD, Maika SD, Satumtira N, Dorris ML, McLean IL, Yanagisawa H, Sayad A, Stagg AJ, Fox GM, Lê O'Brien A, Rehman M, Zhou M, Weiner AL, Splawski JB, Richardson JA, Hammer RE.
Immunol Rev. 1999 Jun;169:209-23. Review.
Repeated measurement of intestinal permeability as an assessment of colitis severity in HLA-B27 transgenic rats.
Kerr SW, Wolyniec WW, Filipovic Z, Nodop SG, Braza F, Winquist RJ, Noonan TC.
J Pharmacol Exp Ther. 1999 Nov;291(2):903-10.
The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation.
Isordia-Salas I, Pixley RA, Sáinz IM, Martínez-Murillo C, Colman RW.
Arch Med Res. 2005 Jan-Feb;36(1):87-95. Review.
The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.
Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernández-Sueiro JL, Balish E, Hammer RE.
J Exp Med. 1994 Dec 1;180(6):2359-64.
Tissue distribution and kininogen gene expression after acute-phase inflammation.
Chao J, Swain C, Chao S, Xiong W, Chao L.
Biochim Biophys Acta. 1988 Mar 17;964(3):329-39.
Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.
Taurog JD, Maika SD, Simmons WA, Breban M, Hammer RE.
J Immunol. 1993 May 1;150(9):4168-78.
Oral treatment with recombinant human interleukin-11 improves mucosal transport in the colon of human leukocyte antigen-B27 transgenic rats.
Venkova K, Keith JC Jr, Greenwood-Van Meerveld B.
J Pharmacol Exp Ther. 2004 Jan;308(1):206-13. Epub 2003 Oct 20.
Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease.
Harnish DC, Albert LM, Leathurby Y, Eckert AM, Ciarletta A, Kasaian M, Keith JC Jr.
Am J Physiol Gastrointest Liver Physiol. 2004 Jan;286(1):G118-25. Epub 2003 Sep 4.
Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation.
Hoentjen F, Welling GW, Harmsen HJ, Zhang X, Snart J, Tannock GW, Lien K, Churchill TA, Lupicki M, Dieleman LA.
Inflamm Bowel Dis. 2005 Nov;11(11):977-85.
Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats.
Aiko S, Grisham MB.
Gastroenterology. 1995 Jul;109(1):142-50.
Supplemental calcium attenuates the colitis-related increase in diarrhea, intestinal permeability, and extracellular matrix breakdown in HLA-B27 transgenic rats.
Schepens MA, Schonewille AJ, Vink C, van Schothorst EM, Kramer E, Hendriks T, Brummer RJ, Keijer J, van der Meer R, Bovee-Oudenhoven IM.
J Nutr. 2009 Aug;139(8):1525-33. Epub 2009 Jun 17.
Amelioration of chronic and spontaneous intestinal inflammation with an antisense oligonucleotide (ISIS 9125) to intracellular adhesion molecule-1 in the HLA-B27/beta2 microglobulin transgenic rat model.
Bowen-Yacyshyn MB, Bennett CF, Nation N, Rayner D, Yacyshyn BR.
J Pharmacol Exp Ther. 2002 Sep;302(3):908-17.
Recombinant human interleukin-11 restores smooth muscle function in the jejunum and colon of human leukocyte antigen-B27 rats with intestinal inflammation.
Greenwood-Van Meerveld B, Venkova K, Keith JC Jr.
J Pharmacol Exp Ther. 2001 Oct;299(1):58-66.
Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2.
Alavi K, Schwartz MZ, Palazzo JP, Prasad R.
J Pediatr Surg. 2000 Jun;35(6):847-51.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on